共 63 条
[1]
Frieri M(2017)Antibiotic resistance J Infect Public Health 10 369-378
[2]
Kumar K(2018)Antimicrobial resistance: a one health perspective Microbiology Spectrum. 6 10-111
[3]
Boutin A(2021)Environmental antimicrobial resistance and its drivers: a potential threat to public health J Glob Antimicrob Resist. 27 101-464
[4]
McEwen SA(2019)Antimicrobial overuse and misuse in the community in Greece and link to antimicrobial resistance using methicillin-resistant J Infect Public Health 12 460-869
[5]
Collignon PJ(2022) as an example Infect Dis Ther 38 857-66
[6]
Samreen I(2020)Estimating the clinical and economic impact of introducing a new antibacterial into Greek clinical practice for the management of hospital-acquired infections with limited treatment options Pharmacoeconomics 19 56-2172
[7]
Ahmad HA(2019)Estimating the value of new antimicrobials in the context of antimicrobial resistance: development and application of a dynamic disease transmission model Lancet Infect Dis 11 996-1129
[8]
Malak HH(2021)Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis Life (Basel). 75 2164-undefined
[9]
Abulreesh S(2020)COVID-19 and antimicrobial resistance: data from the Greek electronic system for the surveillance of antimicrobial resistance-WHONET-Greece (January 2018-March 2021) J Antimicrob Chemother 8 1717030-undefined
[10]
Karakonstantis D(2020)In vitro activity of ceftolozane/tazobactam alone and in combination with amikacin against MDR/XDR Pseudomonas aeruginosa isolates from Greece J Mark Access Health Policy. 3 1122-undefined